tiprankstipranks
Sanara MedTech (SMTI)
NASDAQ:SMTI
US Market
SMTI
Sanara MedTech
RESEARCH TOOLSreports

Sanara MedTech (SMTI) Ratios

47 Followers

Sanara MedTech Ratios

SMTI's free cash flow for Q4 2025 was $0.84. For the 2025 fiscal year, SMTI's free cash flow was decreased by $ and operating cash flow was $0.31. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.80 1.80 2.18 1.38 1.61
Quick Ratio
 1.59 1.59 2.00 1.04 1.33
Cash Ratio
 0.89 0.89 1.04 0.37 0.70
Solvency Ratio
 -0.52 -0.52 -0.10 -0.02 -0.29
Operating Cash Flow Ratio
 0.36 0.36 >-0.01 -0.24 -0.43
Short-Term Operating Cash Flow Coverage
 19.21 19.21 0.00 -5.59 0.00
Net Current Asset Value
$ -33.47M$ -33.47M$ -15.87M$ -10.28M$ 1.30M
Leverage Ratios
Debt-to-Assets Ratio
 0.66 0.66 0.37 0.16 0.01
Debt-to-Equity Ratio
 8.13 8.13 0.82 0.26 0.02
Debt-to-Capital Ratio
 0.89 0.89 0.45 0.21 0.02
Long-Term Debt-to-Capital Ratio
 0.89 0.89 0.44 0.17 0.00
Financial Leverage Ratio
 12.30 12.30 2.24 1.65 1.46
Debt Service Coverage Ratio
 3.40 1.66 -0.59 -0.27 -20.09
Interest Coverage Ratio
 2.93 1.35 -2.15 -8.86 -43.96
Debt to Market Cap
 0.29 0.23 0.11 0.03 0.00
Interest Debt Per Share
 5.95 6.37 4.17 1.48 0.14
Net Debt to EBITDA
 2.68 2.68 -8.82 -22.98 0.70
Profitability Margins
Gross Profit Margin
90.13%90.13%90.61%87.92%86.12%
EBIT Margin
8.87%8.87%-7.83%-6.10%-30.40%
EBITDA Margin
11.45%11.45%-2.15%-0.44%-25.23%
Operating Profit Margin
8.87%8.87%-7.75%-6.49%-27.30%
Pretax Profit Margin
-0.38%-0.38%-11.44%-6.83%-30.40%
Net Profit Margin
-36.43%-36.43%-11.15%-6.62%-17.31%
Continuous Operations Profit Margin
-0.38%-0.38%-11.44%-6.83%-17.65%
Net Income Per EBT
9554.90%9554.90%97.50%96.92%56.95%
EBT Per EBIT
-4.30%-4.30%147.60%105.33%111.34%
Return on Assets (ROA)
-51.50%-51.50%-10.97%-5.83%-13.00%
Return on Equity (ROE)
-178.57%-633.46%-24.53%-9.60%-18.98%
Return on Capital Employed (ROCE)
16.84%16.84%-9.22%-7.01%-25.95%
Return on Invested Capital (ROIC)
16.73%16.73%-9.18%-6.91%-14.97%
Return on Tangible Assets
-74.09%-74.09%-22.23%-16.98%-30.62%
Earnings Yield
-25.27%-18.66%-3.43%-1.26%-2.21%
Efficiency Ratios
Receivables Turnover
 8.59 8.59 6.40 7.62 6.55
Payables Turnover
 4.35 4.35 5.43 3.92 4.46
Inventory Turnover
 2.58 2.58 2.96 1.66 1.79
Fixed Asset Turnover
 40.72 40.72 46.10 19.98 20.62
Asset Turnover
 1.41 1.41 0.98 0.88 0.75
Working Capital Turnover Ratio
 7.17 6.26 7.45 9.96 3.47
Cash Conversion Cycle
 100.18 100.18 113.26 174.15 177.55
Days of Sales Outstanding
 42.47 42.47 57.07 47.92 55.76
Days of Inventory Outstanding
 141.54 141.54 123.45 219.28 203.65
Days of Payables Outstanding
 83.83 83.83 67.25 93.05 81.87
Operating Cycle
 184.01 184.01 180.51 267.20 259.41
Cash Flow Ratios
Operating Cash Flow Per Share
 0.79 0.79 >-0.01 -0.39 -0.70
Free Cash Flow Per Share
 0.25 0.25 -0.03 -0.42 -0.80
CapEx Per Share
 0.54 0.54 0.03 0.03 0.09
Free Cash Flow to Operating Cash Flow
 0.32 0.32 10.64 1.08 1.13
Dividend Paid and CapEx Coverage Ratio
 1.47 1.47 -0.10 -12.24 -7.44
Capital Expenditure Coverage Ratio
 1.47 1.47 -0.10 -12.24 -7.44
Operating Cash Flow Coverage Ratio
 0.14 0.14 >-0.01 -0.28 -6.78
Operating Cash Flow to Sales Ratio
 0.07 0.07 >-0.01 -0.05 -0.12
Free Cash Flow Yield
1.37%1.07%-0.09%-1.03%-1.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.96 -5.36 -29.15 -79.07 -45.32
Price-to-Sales (P/S) Ratio
 1.53 1.95 3.25 5.24 7.85
Price-to-Book (P/B) Ratio
 25.07 33.96 7.15 7.59 8.60
Price-to-Free Cash Flow (P/FCF) Ratio
 73.13 93.17 -1.11K -96.92 -57.09
Price-to-Operating Cash Flow Ratio
 21.90 29.67 -11.84K -104.84 -64.76
Price-to-Earnings Growth (PEG) Ratio
 8.59 -0.02 -0.24 1.65 6.12
Price-to-Fair Value
 25.07 33.96 7.15 7.59 8.60
Enterprise Value Multiple
 16.06 19.73 -160.24 -1.20K -30.40
Enterprise Value
 189.65M 232.96M 298.08M 346.91M 351.62M
EV to EBITDA
 16.06 19.73 -160.24 -1.20K -30.40
EV to Sales
 1.84 2.26 3.44 5.34 7.67
EV to Free Cash Flow
 87.76 107.80 -1.18K -98.81 -55.80
EV to Operating Cash Flow
 27.95 34.33 -12.53K -106.89 -63.30
Tangible Book Value Per Share
 -1.89 -1.89 -0.67 -0.48 0.84
Shareholders’ Equity Per Share
 0.69 0.69 4.64 5.42 5.29
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.42
Revenue Per Share
 11.96 11.96 10.22 7.85 5.80
Net Income Per Share
 -4.36 -4.36 -1.14 -0.52 -1.00
Tax Burden
 95.55 95.55 0.98 0.97 0.57
Interest Burden
 -0.04 -0.04 1.46 1.12 1.00
Research & Development to Revenue
 0.05 0.05 0.07 0.06 0.07
SG&A to Revenue
 0.76 0.76 0.88 0.00 1.00
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.05 0.05 0.06
Income Quality
 -0.25 -0.25 <0.01 0.73 0.69
Currency in USD